BioLineRx (BLRX) Interest Coverage Ratio Growth (3y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 79.36% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 29.25% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -16.86% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1.78% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 40.09% |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 | 48.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.06% |
| Sep 30, 2025 | -35.06% |
| Jun 30, 2025 | -25.35% |
| Mar 31, 2025 | -44.15% |
| Dec 31, 2024 | -68.74% |
| Sep 30, 2024 | -48.18% |
| Jun 30, 2024 | -53.14% |
| Mar 31, 2024 | -34.21% |
| Dec 31, 2023 | -27.78% |
| Sep 30, 2023 | -1.38% |
| Jun 30, 2023 | -19.20% |
| Mar 31, 2023 | -41.79% |
| Dec 31, 2022 | -18.89% |
| Sep 30, 2022 | 33.56% |
| Jun 30, 2022 | 10.86% |
| Mar 31, 2022 | 37.84% |
| Dec 31, 2021 | 14.55% |
| Sep 30, 2021 | -65.19% |
| Jun 30, 2021 | -62.75% |
| Mar 31, 2021 | -17.27% |
| Dec 31, 2020 | -79.30% |
| Sep 30, 2020 | -76.43% |
| Jun 30, 2020 | -79.90% |
| Mar 31, 2020 | -73.46% |
| Dec 31, 2019 | -69.97% |
| Sep 30, 2019 | -78.52% |
| Jun 30, 2019 | -73.30% |
| Mar 31, 2019 | -76.36% |
| Dec 31, 2018 | 26.54% |
| Sep 30, 2018 | 142.52% |
| Jun 30, 2018 | -37.01% |
| Mar 31, 2018 | -49.81% |
| Dec 31, 2017 | 148.18% |
| Sep 30, 2017 | 344.02% |
| Jun 30, 2017 | 477.47% |
| Mar 31, 2017 | 159.91% |
| Dec 31, 2016 | 279.94% |
| Sep 30, 2016 | 474.34% |
| Jun 30, 2016 | 329.04% |
| Mar 31, 2016 | 332.09% |